Ali Saeed, Khetpal Neelam, Khan Muhammad Talha, Rasheed Mamoon, Asad-Ur-Rahman Fnu, Echeverria-Beltran Karen
Internal Medicine Residency, Florida Hospital-Orlando.
Internal Medicine, Khyber Medical College.
Cureus. 2017 Dec 27;9(12):e1992. doi: 10.7759/cureus.1992.
Dientamoeba fragilis (D. fragilis) is an anaerobic intestinal protozoan parasite that has been associated with irritable bowel syndrome (IBS)-like symptoms. We report a case of post-infectious IBS caused by D. fragilis treated successfully with metronidazole. A 33-year-old African American male with an unremarkable past medical history was seen in the office with a three-month history of intermittent, generalized, crampy abdominal pain with bloating and flatulence without associated weight loss. He visited Mexico for his honeymoon four months ago. Initial lab work was normal. Dietary changes including fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) diet and loperamide were prescribed with the presumptive diagnosis of IBS; however, his symptoms persisted. Three samples of stool for ova and parasites (O&P) were positive for D. fragilis. The patient was treated with metronidazole for 14 days. Repeat fecal O&P were negative. Upon follow-up, the patient' symptoms substantially improved with a resolution of abdominal pain and flatulence. Infection caused by D. fragilis may be symptomatic or asymptomatic. It is transmitted by the fecal-oral route. Symptoms include abdominal pain, bloating, and alteration of bowel movements, resembling IBS. The diagnosis is made via the detection of D. fragilis trophozoites in appropriately fixed and stained stool samples or by a polymerase chain reaction. Treatment options include tetracyclines, paromomycin, metronidazole, and Iodoquinol. Further epidemiologic studies may help in elucidating the association between D. fragilis and IBS.
脆弱双核阿米巴(D. fragilis)是一种厌氧性肠道原生动物寄生虫,与肠易激综合征(IBS)样症状有关。我们报告一例由脆弱双核阿米巴引起的感染后肠易激综合征,用甲硝唑成功治疗。一名33岁既往病史无异常的非裔美国男性因间歇性、全身性、痉挛性腹痛伴腹胀和肠胃胀气3个月就诊,无体重减轻。他4个月前度蜜月去了墨西哥。初始实验室检查正常。鉴于初步诊断为肠易激综合征,给予包括可发酵低聚糖、双糖、单糖和多元醇(FODMAP)饮食及洛哌丁胺在内的饮食调整;然而,他的症状持续存在。三份粪便虫卵和寄生虫(O&P)样本检测显示脆弱双核阿米巴呈阳性。患者接受甲硝唑治疗14天。重复粪便O&P检测为阴性。随访时,患者症状显著改善,腹痛和肠胃胀气消失。脆弱双核阿米巴引起的感染可能有症状或无症状。它通过粪口途径传播。症状包括腹痛、腹胀和排便改变,类似于肠易激综合征。诊断通过在适当固定和染色的粪便样本中检测脆弱双核阿米巴滋养体或通过聚合酶链反应进行。治疗选择包括四环素、巴龙霉素、甲硝唑和碘喹啉。进一步的流行病学研究可能有助于阐明脆弱双核阿米巴与肠易激综合征之间的关联。